Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2016 | 03-2015 | 03-2014 | 03-2013 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -683 | 5,221 | -41,261 | 1,488 | -15,058 |
| Depreciation Amortization | 667 | 582 | 454 | 423 | 484 |
| Accounts receivable | 33 | -714 | -67 | -268 | 175 |
| Other Working Capital | 1,874 | -843 | -63 | -900 | 372 |
| Other Operating Activity | -4,656 | -19,348 | 36,720 | -2,437 | 13,633 |
| Operating Cash Flow | $-2,765 | $-15,103 | $-4,217 | $-1,693 | $-394 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,919 | -1,965 | -502 | -153 | -623 |
| Sale Of Investment | N/A | 5,000 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -58 | -52 | -45 |
| Other Investing Activity | -30 | -156 | -55 | -39 | -35 |
| Investing Cash Flow | $-1,949 | $2,879 | $-558 | $-192 | $-658 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 54 | 529 | 600 | N/A |
| Debt Repayment | -210 | -1,110 | N/A | N/A | N/A |
| Common Stock Issued | 9,241 | 14,038 | 10,868 | 565 | N/A |
| Other Financing Activity | -269 | -235 | -50 | 421 | -106 |
| Financing Cash Flow | $8,762 | $12,746 | $11,347 | $1,586 | $-106 |
| Beginning Cash Position | 7,464 | 6,942 | 369 | 668 | 1,826 |
| End Cash Position | 11,512 | 7,464 | 6,942 | 369 | 668 |
| Net Cash Flow | $4,048 | $522 | $6,573 | $-299 | $-1,158 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,765 | -15,103 | -4,217 | -1,693 | -394 |
| Capital Expenditure | -1,919 | -1,965 | -502 | -153 | -623 |
| Free Cash Flow | -4,684 | -17,068 | -4,719 | -1,846 | -1,017 |